The clinical significance of hpv

Nurse Practitioner

Volumn 28, Issue 10, 2003, Pages 8-19

  Heise, Alana ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645282671     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/00006205-200310000-00008     Document Type: Article

References (48)

1. Ho GY, Bierman R, Beardsley L, et al: Natural history of cervicovaginal papillomavirus infection in young women. N Eng J Med 1998; 338:423-28.
2. Walboomers JM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19.
3. Bosch FX, Manos MM, Munoz N, et al: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87(11):796-802.
4. rd edition. Washington DC:ASM Press, 2000;374-83.
5. Benenson, AS (ed): Control of communicable diseases manual. Washington, DC: American Public Health Association, 1995;514-516.
6. Yamada Y, Manos MM, Peto J, et al: Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997; 71:2463-72.
7. Beutner KR, Tyring S: Human papillomavirus and human disease. Am J Med 1997; 102(5A):9-15.
8. Stubenrauch F, Laimins LA: Human papillomaviruses life cycle:active and latent phases. Sem Cancer Biol 1999; 9:379-86.
9. Koutsky L: Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102(5A):3-8.
10. Trofatter, KF: Diagnosis of human papillomavirus genital tract infection. Am J Med 1997; 102(5A):21-27.
11. Handsfield HH: Clinical presentation and natural course of anogenital warts. Am J Med 1997; 102(5A):16-20.
12. Mao C, Hughes JP, Kiviat N, et al.: Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol 2003; 188:677-84.
13. Simsir A, Ioffe OB, Bourquin P, et al.: Repeat cytology at the time of colposcopy. Acta Cytol 2001; 45:23-27.
14. Wright TC, Cox JT, Massad LS, et al: 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287(16):2120-2129.
15. Schiffman M, Adrianza ME: ASCUS-LSIL triage study. Design, methods and characteristics of trial participants. Acta Cytol 2000; 44:726-42.
16. Coker AL, Sanders LC, Bond SM, et al: Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development. J Women’s Health Gender-Based Med 2001; 10:441-49.
17. National Cancer Institute. Cancer statistics 1998. Website.
18. Cates W, The American Social Health Association Panel: Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Trans Dis 1999; 26(4) Suppl.:S2-S6.
19. American Cancer Society, Cervical cancer: statistics.
20. van Bogaert LJ, Knapp DC: Opportunistic testing of medically underserved women for cervical cancer in South Africa. Acta Cytol 2001; 45:313-16.
21. rd edition. Philadelphia, PA.: Lippincott Williams and Wilkins, 2001;21-137, 195-219.
22. th edition. Philadelphia, PA.:Lippincott Williams &Wilkins, 2001;2197-2229.
23. th edition. Philadelphia, PA.:Lippincott Williams &Wilkins, 2001;2231-2264.
24. Flores ER, Allen-Hoffmann BL, Lee D, et al.: The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J Virol 2000; 74(4):6622-31.
25. Flores ER, Lambert PF: Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J Virol 1997; 71:7167-79.
26. Steenbergen Rd, Parker JN, Isern S, et al.: Ciral E6-E7 transcription in the basla layer of organotypis cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16− and 18− transfected human kerantinocytes. J Virol 1998; 72(1);749-57.
27. Jeon S, Allen-Hoffmann BL, Lambert PF: Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995; 69:2989-2997.
28. de Boer CJ, van Dorst E, van Krieken H, et al: Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am J Pathol 1999; 155:505-515.
29. th edition. Philadelphia, PA.:WB Saunders, 1999;260-328.
30. Beutner KR, Ferenczy A: Therapeutic approaches to genital warts. Am J Med 1997; 102(5A):28-37.
31. Chang CL, Wang SY, Wu CC, et al.: Microsatellite alterations in exfoliated cervical epithelia deoxyribonucleic acid as a marker for high-grade dysplasia. Am J Obstet Gynecol 2001; 185:108-15.
32. Schiller J, Lowy D: Papillomavirus-like particle vaccines. J Natl Cancer Inst Monogr 2001(28):50-4.
33. Marais D, Passmore J, Maclean J, et al: A recombinant human papillomavirus (HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles. J Gen Virol 1999; 80:2471-75.
34. White WI, Wilson SD, Pamer-Hill FJ, et al: Characterizations of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol 1999; 73:4882-9.
35. White WI, Wilson SD, Bonnez, W, et al.: In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. J Virol 1998; 72:959-964.
36. Harro CD, Pang YS, Roden, RB, et al.: Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst 2001; 93:284-92.
37. Starfield B: Basic concepts in population health and health care. J Epidem Comm Health 2001; 55:452-53.
38. Reitano M: Counseling patients with genital warts. Am J Med 1997; 102(5A):38-43.
39. Savick CA. (ed). Sex sense. Canadian contraceptive guide.Ottawa, ON.:Society of Obstetricians and Gynecologists of Canada, 2000.
40. Moens F: Cervical cancer screening: Beyond the wall. Can J CME 1995;Nov:51-61.
41. Schneider V, Henry MR, Jimenez-Ataya M, et al.: Cervical cancer screening, screening errors and reporting. Acta Cytol 2001; 45:493-98.
42. Fahey MT, Irwig L, Macaskill P: Meta-analysis of pap test accuracy. Am J Epidemiol 1995; 141:680-89.
43. Park IA, Lee SN, Chae SW, et al: Comparing the accuracy of ThinPrep pap tests and conventional papanicolaou smears on the basis of histologic diagnosis. Acta Cytol 2001; 45:525-31.
44. Bergeron C, Bishop J, Lemarie A, et al: Accuracy of thin-layer cytology in patients undergoing cervical cone biopsy. Acta Cytol 2001; 45:519-524.
45. Lakewood Pathology Associates, Women’s health: cervical cancer. Updated August 2001. Website.
46. Solomon D, Schiffman M, Tarone R: Comparison of three management strategies for Patients with atypical cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001; 93:293-99.
47. Wallin KL, Wiklund F, Angstrom T, et al: Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Eng J Med 1999; 341:1633-1638.
48. Sherman ME, Solomon D, Schiffman M: Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL triage study. Am J Clin Path 2001; 116:386-94.